Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Switching of supramolecular nanostructures at the solid-liquid interface: interplay of bias polarity and solution concentration.

Nanoscale advances·2025
Same author

Comparing Adsorption of an Electron-Rich Triphenylene Derivative: Metallic vs Graphitic Surfaces.

The journal of physical chemistry. C, Nanomaterials and interfaces·2024
Same author

The association between endometrial polyps, chronic endometritis, and IVF outcomes.

European review for medical and pharmacological sciences·2023
Same author

Vaccine hesitancy educational tools for healthcare providers and trainees: A scoping review.

Vaccine·2022
Same author

Length-dependent symmetry in narrow chevron-like graphene nanoribbons.

Nanoscale advances·2022
Same author

Self-Assembly of a Triphenylene-Based Electron Donor Molecule on Graphene: Structural and Electronic Properties.

The journal of physical chemistry. C, Nanomaterials and interfaces·2022
Same journal

Severe Persistent Hypereosinophilia of Undetermined Significance: Diagnostic Challenges in Clinical Practice and Two-Year Follow-Up.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2026
Same journal

Immune Checkpoint Inhibitor-Associated Myocarditis: A Retrospective Case Series.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2026
Same journal

Mortality predictors in patients with ST-segment elevation myocardial infarction presenting no-reflow phenomenon after primary PCI: experience of a tertiary center.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2026
Same journal

Pancreatic stone protein predicts hospital stay in community-acquired infections.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2026
Same journal

Clinical features and hematological indices predicting all-cause mortality in patients undergoing hemodialysis; a retrospective cohort study.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2026
Same journal

Clinical construct validity and subgroup stability of the Romanian version of the Boston Carpal Tunnel Questionnaire in nerve-conduction-confirmed carpal tunnel syndrome - a cross-sectional study.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2026
See all related articles

Related Experiment Video

Updated: Jun 26, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

Polycystic hepatic disease.

I Copaci1, Mihaela Enache, C Jurcut

  • 13rd Internal Medicine Department, Carol Davila Central Clinical Emergency Military Hospital, Bucharest, Romania. iulian_copaci@yahoo.com

Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne
|January 23, 2009
PubMed
Summary
This summary is machine-generated.

Polycystic hepatic disease is a rare genetic disorder causing liver cysts. This case highlights normal liver function despite extensive hepatic cysts, a rare presentation of this condition.

More Related Videos

A High-Throughput In Situ Method for Estimation of Hepatocyte Nuclear Ploidy in Mice
08:44

A High-Throughput In Situ Method for Estimation of Hepatocyte Nuclear Ploidy in Mice

Published on: April 19, 2020

Related Experiment Videos

Last Updated: Jun 26, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

A High-Throughput In Situ Method for Estimation of Hepatocyte Nuclear Ploidy in Mice
08:44

A High-Throughput In Situ Method for Estimation of Hepatocyte Nuclear Ploidy in Mice

Published on: April 19, 2020

Area of Science:

  • Hepatology
  • Genetics
  • Rare Diseases

Background:

  • Polycystic hepatic disease (PHD) is an uncommon inherited disorder.
  • It is characterized by the development of multiple cysts within the liver.
  • Associated renal cysts are common, with rare involvement of other organs.

Observation:

  • A rare case of polycystic hepatic disease is presented.
  • The patient's liver structure was almost entirely replaced by cysts.
  • Despite the extensive cystic replacement, liver function tests remained within normal limits.

Findings:

  • Extensive hepatic cysts can occur in polycystic hepatic disease.
  • Preserved liver function is possible even with near-complete replacement of hepatic structure by cysts.
  • This presentation is unusual for polycystic hepatic disease.

Implications:

  • This case expands the understanding of the clinical spectrum of polycystic hepatic disease.
  • It suggests that extensive hepatic cystic disease does not always correlate with impaired liver function.
  • Further research into the mechanisms of preserved liver function in such cases is warranted.